jRCT2080224827已完成2 期
Phase II clinical study of TY-0305 in symptomatic patients with hypertrophic obstructive cardiomyopathy -A pilot study-
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Multicenter, single-arm, open-label study
- 主要目的
- Treatment Purpose
入排标准
- 年龄范围
- 20age old over 至 75age old under（—）
- 性别
- All
入选标准
- •(1) Patients with New York Heart Association (NHYA) functional class II or III.
- •(2) Patients able to perform the cardiopulmonary exercise test.
排除标准
- •(1) Patients with past or current medical history of persistent ventricular tachycardia or ventricular fibrillation.
- •(2) Patients with persistent or permanent atrial fibrillation.
- •(3) Patients with past or current medical history of coronary artery disease.
结局指标
主要结局
-
efficacy Peak oxygen uptake
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Phase II clinical study of TY-0305 in symptomatic patients with hypertrophic obstructive cardiomyopathy -A pilot studySymptomatic hypertrophic obstructive cardiomyopathyJPRN-jRCT2080224827TOA EIYO LTD.10
未知
2 期
Phase II clinical study of TY-0201 in patients with chronic heart failureChronic heart failureJPRN-jRCT2080222593TOA EIYO LTD.40
未知
2 期
Phase II clinical study of TY-51924 in patients with acute myocardial infarction - Pilot studyAcute myocardial infarctionJPRN-jRCT2080221349TOA EIYO LTD.
未知
2 期
Proof of concept study of TY-51924 in patients with acute myocardial infarctioAcute myocardial infarctionJPRN-jRCT2080221705TOA EIYO LTD.100
招募中
1 期
Study of LY3537982 in Cancer Patients with a Specific Genetic Mutation (KRAS G12C)SCLCCRCEndometrial NeoplasmsOvarian NeoplasmsPancreatic NeoplasmsBiliary Tract NeoplasmsFrontline, 1L, First LineJPRN-jRCT2031210265Masaki Takeshi80